The money will fund its preclinical immuno-oncology programs. It also hired Achaogen exec Adrian Jubb as chief medical officer and Genentech's An Song as SVP of development sciences.
The funding will be used to expand the commercial operations of the company's visualization and quantification algorithm for medical imaging.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.